Hepatitis B surface antigen (HBsAg) prevalence (%) in Vanuatu
Vanuatu: Hepatitis B surface antigen (HBsAg) prevalence was 1.8% in 2024. ▬ Flat
Latest (2024)
1.8%
Change on year
up 5.9%
World rank
13th
of 194 countries
All-time high
1.8%
in 2024
All-time low
1.5%
in 2019
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Vanuatu, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
In 2024, hepatitis b surface antigen (hbsag) prevalence in Vanuatu stood at 1.8%. That is the highest value across all 10 years on record.
The figure is up 5.9% on the previous year and up 5.9% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Vanuatu peaked at 1.8% in 2024 and was at its lowest, 1.5%, in 2019.
That places Vanuatu 13th out of 194 countries with data for 2024, putting it in the top 10%.
Hepatitis B surface antigen (HBsAg) prevalence in Vanuatu, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.7% | — |
| 2016 | 1.7% | +0.0% |
| 2017 | 1.6% | -5.9% |
| 2018 | 1.6% | +0.0% |
| 2019 | 1.5% | -6.3% |
| 2020 | 1.5% | +0.0% |
| 2021 | 1.6% | +6.7% |
| 2022 | 1.7% | +6.2% |
| 2023 | 1.7% | +0.0% |
| 2024 | 1.8% | +5.9% |
Vanuatu compared with similar countries
- Vanuatu's 1.8% is above the median for lower middle income countries, which is 0.6%, 3.0× the median. (47 countries reporting)
- Vanuatu's 1.8% is above the median for East Asia & Pacific, which is 0.6%, 3.0× the median. (30 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.6% | 1.5% | 1.7% | 5 |
| 2020s | 1.7% | 1.5% | 1.8% | 5 |
Countries ranked near Vanuatu
More health data for Vanuatu
- Un projection of annual infant deaths, annual growth rate -2.22 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.8846 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 695.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 44 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.3888 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0639 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.395 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Vanuatu?
- Hepatitis b surface antigen (hbsag) prevalence in Vanuatu was 1.8% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Vanuatu?
- The highest recorded value was 1.8% in 2024.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Vanuatu?
- The lowest recorded value was 1.5% in 2019.
- How does Vanuatu rank for hepatitis b surface antigen (hbsag) prevalence?
- Vanuatu ranks 13th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Vanuatu?
- Over the last ten years it is up 5.9%. The long-run trend across the full record is flat.
- Where does this Vanuatu data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).